Predict your next investment

Dxcover company logo
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
dxcover.com

See what CB Insights has to offer

Founded Year

2016

Stage

Series A - II | Alive

Total Raised

$6.23M

Last Raised

$1.54M | 7 mos ago

About Dxcover

Dxcover, fka ClinSpec Diagnostics, develops a spectroscopic method for blood serum analysis, allowing same-day detection and grading of a range of diseases, with first applications to brain cancer.

Dxcover Headquarter Location

Suite RC534, Royal College Building 204 George Street

Glasgow, Scotland, G1 1XW,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Dxcover

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Dxcover is included in 5 Expert Collections, including Medical Devices.

M

Medical Devices

7,528 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Cancer

3,592 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health & Wellness Assessment

2,359 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

N

Neuroscience

2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

C

Cancer Liquid Biopsies

105 items

Products/services that analyze tumor-derived biomarkers (ctDNA, CTCs, exosomes) in blood/urine/other non-invasive liquid specimens to detect cancer earlier, guide treatment, and monitor progress. *Data fields manually updated as new information becomes available.'

Dxcover Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Dxcover Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.